GLP Watchdog

GobyMeds vs RxION Health

Neither GobyMeds nor RxION Health has an FDA warning letter on record. On brand-name semaglutide pen, RxION Health costs $2,352 less a year at standing rates: $1,499 a month against $1,695 a month at GobyMeds. It is one of four products the two sell at comparable terms.

By Ruth Calder · Enforcement Editor
Editorially reviewed. Not medical advice · How we verify contentLast reviewed

The record

GobyMeds / RxION Health

GobyMeds logo

GobyMeds

7.7/10

RxION Health logo

RxION Health

8.3/10

FDA warning letters
None on record
None on record
Pharmacy
  • Precision Medicinetype not stated
  • HealthWarehouse.comtype not stated
  • The Pharmacy Hub503A
  • and 1 more
None named in our record
Lowest standing price
$169/moCompounded semaglutide injection
$149/moCompounded semaglutide injection
States
No state list published
47 states
Checked
Prices captured Record checked October 2026
Prices captured Record checked October 2026
Visit GobyMedsFull review
Visit RxION HealthFull review

Neither GobyMeds nor RxION Health pays us. Links to them earn nothing. Scores: GobyMeds 7.7, RxION Health 8.3. How we are paid

What the record shows

  1. 01

    Neither GobyMeds nor RxION Health has an FDA warning letter on record.

  2. 02

    GobyMeds names four pharmacies. RxION Health names no compounding pharmacy in our record.

  3. 03

    On brand-name semaglutide pen, RxION Health costs $2,352 less a year at standing rates: $1,499 a month against $1,695 a month at GobyMeds. It is one of four products the two sell at comparable terms.

  4. 04

    RxION Health lists 47 states. GobyMeds publishes no state list.

Prices and terms, product by product

A price is set against the other side only for the same product, and only when both are standing monthly or 4-week rates. Those pairs are compared by yearly cost.

GobyMeds

RxION Health

Compounded semaglutide injection

$169/mo

$2,028 a year

$149/moLower

$1,788 a year

Compounded tirzepatide injection

$299/mo

$3,588 a year

$199/moLower

$2,388 a year

Brand-name semaglutide pen

$1,695/mo

$20,340 a year

$1,499/moLower

$17,988 a year

Brand-name tirzepatide pen

$1,399/mo

$16,788 a year

$1,259/moLower

$15,108 a year

Price includes
Medication, clinician visits, shipping
Medication, clinician visits, shipping
Cancel any time
Yes, stated
Yes, stated
Minimum term
None; each bundle or month is a one-time purchase
None on the monthly plan; prepaid plans cover 3 or 6 months
Refunds
All prescriptions are final sale and non-refundable
Medication portion refunded if not approved; the $75 consult fee and issued prescriptions are not refundable
Early-exit fee
None stated
None stated

Read off each seller’s own pages. GobyMeds: October 17, 2026. RxION Health: October 17, 2026. Every plan and dose we hold is on the full review.

The case for each

The case for GobyMeds

7.7/10
  • Names its compounding pharmacy
  • Publishes no state list
Visit GobyMeds

The case for RxION Health

8.3/10
  • $240 a year less on compounded semaglutide injection
  • $1,200 a year less on compounded tirzepatide injection
  • Names no compounding pharmacy
Visit RxION Health

Scores

GobyMeds 7.7 · RxION Health 8.3 out of 10. Six weighted parts.

Value25%

6.2A
vs
B
7.1

Effectiveness25%

10.0A
vs
B
10.0

User Experience15%

8.0A
vs
B
8.0

Trust & Safety15%

8.0A
vs
B
7.5

Accessibility10%

5.0A
vs
B
9.5

Support10%

7.0A
vs
B
7.0

The score is the same formula for every seller. Payment does not enter it. Method

GobyMeds vs RxION Health: questions

Neither GobyMeds nor RxION Health has an FDA warning letter on record. Letters are matched to a seller by company, domain and address, never by a similar name.
GobyMeds names four pharmacies. RxION Health names no compounding pharmacy in our record. A 503A pharmacy compounds for named patients on a prescription; a 503B outsourcing facility is registered with FDA and inspected under federal manufacturing rules.
RxION Health, by $240 a year at standing rates. GobyMeds: $169 a month, about $2,028 a year. RxION Health: $149 a month, about $1,788 a year.
GobyMeds states you can cancel at any time; refunds: all prescriptions are final sale and non-refundable. RxION Health states you can cancel at any time; refunds: medication portion refunded if not approved; the $75 consult fee and issued prescriptions are not refundable.
Neither GobyMeds nor RxION Health pays us. Links to them earn nothing. Scores: GobyMeds 7.7, RxION Health 8.3.

Other sellers we are paid by

Affiliate partners outside this pair. Each has its own record and review, scored the same way.

Sellers closest to these two

Matched on molecule, form and price. Every pair we list · The register

Brand names on this page are registered marks. Novo Nordisk holds Wegovy®, Ozempic® and Rybelsus®; Eli Lilly holds Zepbound®, Mounjaro® and Foundayo®. Neither company has any tie to GLP Watchdog. Trademarks